BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38468469)

  • 21. Clinical practice guidelines for the management of adult diffuse gliomas.
    Jiang T; Nam DH; Ram Z; Poon WS; Wang J; Boldbaatar D; Mao Y; Ma W; Mao Q; You Y; Jiang C; Yang X; Kang C; Qiu X; Li W; Li S; Chen L; Li X; Liu Z; Wang W; Bai H; Yao Y; Li S; Wu A; Sai K; Li G; Yao K; Wei X; Liu X; Zhang Z; Dai Y; Lv S; Wang L; Lin Z; Dong J; Xu G; Ma X; Zhang W; Zhang C; Chen B; You G; Wang Y; Wang Y; Bao Z; Yang P; Fan X; Liu X; Zhao Z; Wang Z; Li Y; Wang Z; Li G; Fang S; Li L; Liu Y; Liu S; Shan X; Liu Y; Chai R; Hu H; Chen J; Yan W; Cai J; Wang H; Chen L; Yang Y; Wang Y; Han L; Wang Q; ; ; ; ;
    Cancer Lett; 2021 Feb; 499():60-72. PubMed ID: 33166616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
    Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
    Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Speckled Protein (SP) Family: Immunity's Chromatin Readers.
    Fraschilla I; Jeffrey KL
    Trends Immunol; 2020 Jul; 41(7):572-585. PubMed ID: 32386862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene Ontology Semantic Similarity Analysis Using GOSemSim.
    Yu G
    Methods Mol Biol; 2020; 2117():207-215. PubMed ID: 31960380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.
    Hu H; Mu Q; Bao Z; Chen Y; Liu Y; Chen J; Wang K; Wang Z; Nam Y; Jiang B; Sa JK; Cho HJ; Her NG; Zhang C; Zhao Z; Zhang Y; Zeng F; Wu F; Kang X; Liu Y; Qian Z; Wang Z; Huang R; Wang Q; Zhang W; Qiu X; Li W; Nam DH; Fan X; Wang J; Jiang T
    Cell; 2018 Nov; 175(6):1665-1678.e18. PubMed ID: 30343896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CancerSEA: a cancer single-cell state atlas.
    Yuan H; Yan M; Zhang G; Liu W; Deng C; Liao G; Xu L; Luo T; Yan H; Long Z; Shi A; Zhao T; Xiao Y; Li X
    Nucleic Acids Res; 2019 Jan; 47(D1):D900-D908. PubMed ID: 30329142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway.
    Li L; Qi Y; Ma X; Xiong G; Wang L; Bao C
    Cell Biol Int; 2018 Sep; 42(9):1192-1199. PubMed ID: 29762880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
    Zhu GS; Tang LY; Lv DL; Jiang M
    Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance of macrophage transcriptional programs and intestinal homeostasis by epigenetic reader SP140.
    Mehta S; Cronkite DA; Basavappa M; Saunders TL; Adiliaghdam F; Amatullah H; Morrison SA; Pagan JD; Anthony RM; Tonnerre P; Lauer GM; Lee JC; Digumarthi S; Pantano L; Ho Sui SJ; Ji F; Sadreyev R; Zhou C; Mullen AC; Kumar V; Li Y; Wijmenga C; Xavier RJ; Means TK; Jeffrey KL
    Sci Immunol; 2017 Mar; 2(9):. PubMed ID: 28783698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme.
    Sokratous G; Polyzoidis S; Ashkan K
    Hum Vaccin Immunother; 2017 Nov; 13(11):2575-2582. PubMed ID: 28362548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL11 promotes angiogenic activity by activating the PI3K/Akt pathway in HUVECs.
    Park JY; Kang YW; Choi BY; Yang YC; Cho BP; Cho WG
    J Recept Signal Transduct Res; 2017 Aug; 37(4):416-421. PubMed ID: 28279120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimethyloxaloylglycine Promotes the Angiogenic Activity of Mesenchymal Stem Cells Derived from iPSCs via Activation of the PI3K/Akt Pathway for Bone Regeneration.
    Zhang J; Guan J; Qi X; Ding H; Yuan H; Xie Z; Chen C; Li X; Zhang C; Huang Y
    Int J Biol Sci; 2016; 12(6):639-52. PubMed ID: 27194942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole Genome DNA Methylation Analysis of Obstructive Sleep Apnea: IL1R2, NPR2, AR, SP140 Methylation and Clinical Phenotype.
    Chen YC; Chen TW; Su MC; Chen CJ; Chen KD; Liou CW; Tang P; Wang TY; Chang JC; Wang CC; Lin HC; Chin CH; Huang KT; Lin MC; Hsiao CC
    Sleep; 2016 Apr; 39(4):743-55. PubMed ID: 26888452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.
    Patel AP; Tirosh I; Trombetta JJ; Shalek AK; Gillespie SM; Wakimoto H; Cahill DP; Nahed BV; Curry WT; Martuza RL; Louis DN; Rozenblatt-Rosen O; Suvà ML; Regev A; Bernstein BE
    Science; 2014 Jun; 344(6190):1396-401. PubMed ID: 24925914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SP110 gene polymorphisms and tuberculosis susceptibility: a systematic review and meta-analysis based on 10 624 subjects.
    Lei X; Zhu H; Zha L; Wang Y
    Infect Genet Evol; 2012 Oct; 12(7):1473-80. PubMed ID: 22691368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research.
    Asplund A; Edqvist PH; Schwenk JM; Pontén F
    Proteomics; 2012 Jul; 12(13):2067-77. PubMed ID: 22623277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
    ; ; Sawcer S; Hellenthal G; Pirinen M; Spencer CC; Patsopoulos NA; Moutsianas L; Dilthey A; Su Z; Freeman C; Hunt SE; Edkins S; Gray E; Booth DR; Potter SC; Goris A; Band G; Oturai AB; Strange A; Saarela J; Bellenguez C; Fontaine B; Gillman M; Hemmer B; Gwilliam R; Zipp F; Jayakumar A; Martin R; Leslie S; Hawkins S; Giannoulatou E; D'alfonso S; Blackburn H; Martinelli Boneschi F; Liddle J; Harbo HF; Perez ML; Spurkland A; Waller MJ; Mycko MP; Ricketts M; Comabella M; Hammond N; Kockum I; McCann OT; Ban M; Whittaker P; Kemppinen A; Weston P; Hawkins C; Widaa S; Zajicek J; Dronov S; Robertson N; Bumpstead SJ; Barcellos LF; Ravindrarajah R; Abraham R; Alfredsson L; Ardlie K; Aubin C; Baker A; Baker K; Baranzini SE; Bergamaschi L; Bergamaschi R; Bernstein A; Berthele A; Boggild M; Bradfield JP; Brassat D; Broadley SA; Buck D; Butzkueven H; Capra R; Carroll WM; Cavalla P; Celius EG; Cepok S; Chiavacci R; Clerget-Darpoux F; Clysters K; Comi G; Cossburn M; Cournu-Rebeix I; Cox MB; Cozen W; Cree BA; Cross AH; Cusi D; Daly MJ; Davis E; de Bakker PI; Debouverie M; D'hooghe MB; Dixon K; Dobosi R; Dubois B; Ellinghaus D; Elovaara I; Esposito F; Fontenille C; Foote S; Franke A; Galimberti D; Ghezzi A; Glessner J; Gomez R; Gout O; Graham C; Grant SF; Guerini FR; Hakonarson H; Hall P; Hamsten A; Hartung HP; Heard RN; Heath S; Hobart J; Hoshi M; Infante-Duarte C; Ingram G; Ingram W; Islam T; Jagodic M; Kabesch M; Kermode AG; Kilpatrick TJ; Kim C; Klopp N; Koivisto K; Larsson M; Lathrop M; Lechner-Scott JS; Leone MA; Leppä V; Liljedahl U; Bomfim IL; Lincoln RR; Link J; Liu J; Lorentzen AR; Lupoli S; Macciardi F; Mack T; Marriott M; Martinelli V; Mason D; McCauley JL; Mentch F; Mero IL; Mihalova T; Montalban X; Mottershead J; Myhr KM; Naldi P; Ollier W; Page A; Palotie A; Pelletier J; Piccio L; Pickersgill T; Piehl F; Pobywajlo S; Quach HL; Ramsay PP; Reunanen M; Reynolds R; Rioux JD; Rodegher M; Roesner S; Rubio JP; Rückert IM; Salvetti M; Salvi E; Santaniello A; Schaefer CA; Schreiber S; Schulze C; Scott RJ; Sellebjerg F; Selmaj KW; Sexton D; Shen L; Simms-Acuna B; Skidmore S; Sleiman PM; Smestad C; Sørensen PS; Søndergaard HB; Stankovich J; Strange RC; Sulonen AM; Sundqvist E; Syvänen AC; Taddeo F; Taylor B; Blackwell JM; Tienari P; Bramon E; Tourbah A; Brown MA; Tronczynska E; Casas JP; Tubridy N; Corvin A; Vickery J; Jankowski J; Villoslada P; Markus HS; Wang K; Mathew CG; Wason J; Palmer CN; Wichmann HE; Plomin R; Willoughby E; Rautanen A; Winkelmann J; Wittig M; Trembath RC; Yaouanq J; Viswanathan AC; Zhang H; Wood NW; Zuvich R; Deloukas P; Langford C; Duncanson A; Oksenberg JR; Pericak-Vance MA; Haines JL; Olsson T; Hillert J; Ivinson AJ; De Jager PL; Peltonen L; Stewart GJ; Hafler DA; Hauser SL; McVean G; Donnelly P; Compston A
    Nature; 2011 Aug; 476(7359):214-9. PubMed ID: 21833088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SP100 reduces malignancy of human glioma cells.
    Held-Feindt J; Hattermann K; Knerlich-Lukoschus F; Mehdorn HM; Mentlein R
    Int J Oncol; 2011 Apr; 38(4):1023-30. PubMed ID: 21274506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
    Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
    Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
    Gao B; Duan Z; Xu W; Xiong S
    Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.